Skip to main content

Research Repository

Advanced Search

Outputs (5)

The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM) (2021)
Journal Article
Stedman, M., Rea, R., Duff, C. J., Livingston, M., McLoughlin, K., Wong, L., …Heald, A. H. (2022). The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM). https://doi.org/10.1002/edm2.302

BACKGROUND: Finger prick blood glucose (BG) monitoring remains a mainstay of management in people with type 2 diabetes (T2DM) who take sulphonylurea (SU) drugs or insulin. We recently examined patient experience of BG monitoring in people with type 1... Read More about The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM).

Recalibration of thinking about adrenocortical function assessment: how the 'random' cortisol relates to the short synacthen test results (2021)
Journal Article
Michaelidou, M., Yadegarfar, G., Morris, L., Dolan, S., Robinson, A., Naseem, A., …Heald, A. H. (2021). Recalibration of thinking about adrenocortical function assessment: how the 'random' cortisol relates to the short synacthen test results. Cardiovascular Endocrinology & Metabolism, 10(2), 137 - 145. https://doi.org/10.1097/XCE.0000000000000250

Background The short synacthen test (SST) is the most commonly performed investigation to assess adrenal function. Appropriate criteria for when an SST is performed are subject to debate. We investigated how random serum cortisol levels relate to SST... Read More about Recalibration of thinking about adrenocortical function assessment: how the 'random' cortisol relates to the short synacthen test results.

Serum lithium test requesting across three UK regions: an evaluation of adherence to monitoring guidelines (2021)
Journal Article
Parfitt, C., Duff, C. J., Scargill, J., Green, L., Holland, D., Heald, A. H., & Fryer, A. A. (2021). Serum lithium test requesting across three UK regions: an evaluation of adherence to monitoring guidelines. BMC Psychiatry, 21, Article 32. https://doi.org/10.1186/s12888-020-03023-y

BACKGROUND: Bipolar disorder is the fourth most common mental health condition, affecting ~?1% of UK adults. Lithium is an effective treatment for prevention of relapse and hospital admission, and is widely recommended as a first-line treatment. We p... Read More about Serum lithium test requesting across three UK regions: an evaluation of adherence to monitoring guidelines.